Flunixin meglumine
- Level
- Commodity
- Parent
- 51383900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51383906This classification denotes a nonsteroidal antiinflammatory drug C14H11F3N2O2.C7H17NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8Y3JK0JW3U, chemically known as 2-(.alpha.(sup 3),.alpha.(sup 3),.alpha.(sup 3)-trifluoro-2,3-xylidino)nicotinic acid compound with 1-deoxy-1-(methylamino)-d-glucitol (1:1), but more generally known as flunixin meglumine, which bears US NIH Compound Identifier 39212. Most nations, for tariff and trade purposes, schedule flunixin meglumine under HS 29333999 and SITC 51574. As of Q4 2014, FLUNIXIN MEGLUMINE remains US FDA's Preferred Term for this commodity. Flunixin meglumine bears US NLM identifiers UMLS ID C0060503 and NCI Concept Code C76804. SMILES: CC1C(CCCC1NC2C(CCCN2)C(=O)O)C(F)(F)F.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.
Same parent
Under 51383900 · 6Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.